Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study

Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study

Abstract Background In moderate-to-high malaria transmission regions, the World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) alongside insecticide-treated bed nets to reduce the adverse consequences of pregnancy-associated m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elvin Lufele, Sophie Pascoe, Alice Mengi, Alma Auwun, Nalisa Neuendorf, John W. Bolnga, Moses Laman, Stephen J. Rogerson, Kamala Thriemer, Holger W. Unger
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Malaria Journal
Subjects:	Acceptability Dihydroartemisinin-piperaquine Intermittent preventive treatment in pregnancy Malaria Papua New Guinea Pregnancy
Online Access:	https://doi.org/10.1186/s12936-024-05233-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysisResearch in context
by: Michelle E. Roh, et al.
Published: (2025-05-01)

Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia
by: Fanny Arcelia, et al.
Published: (2023-05-01)

Acceptability of dihydroartemisinin-piperaquine as malaria intermittent preventive treatment for pregnant women living with HIV in Southern Mozambique
by: Tacilta Nhampossa, et al.
Published: (2025-05-01)

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
by: Alphonse Ouédraogo, et al.
Published: (2024-12-01)

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
by: Abel Nhama, et al.
Published: (2025-07-01)

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
by: Badara Cisse, et al.
Published: (2009-09-01)

Detection of Falsified Antimalarial Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine Drugs Using a Low-Cost Handheld Near-Infrared Spectrometer
by: Moussa Yabré, et al.
Published: (2022-01-01)

Dihydroartemisinin enhances remyelination by switching microglia to the reparative phenotype
by: Li Liu, et al.
Published: (2025-08-01)

Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria
by: Azrin N. Abd-Rahman, et al.
Published: (2024-11-01)

Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study
by: Yuenan Wang, et al.
Published: (2025-03-01)

Biomineralized apoferritin nanoparticles delivering dihydroartemisinin and calcium for synergistic breast cancer therapy
by: Shanshan Zhao, et al.
Published: (2024-11-01)

Single-atom nanozyme-mediated dihydroartemisinin delivery for self-enhanced chemodynamic therapy and ferroptosis
by: Yuanlong Zhang, et al.
Published: (2025-10-01)

Conceptualizing the implementation of post-discharge malaria chemoprevention in Malawi using a co-design approach
by: Myness Kasanda Ndambo, et al.
Published: (2025-02-01)

Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization
by: Guihua Hang, et al.
Published: (2025-04-01)

Dihydroartemisinin Modulates Enteric Glial Cell Heterogeneity to Alleviate Colitis
by: Peishan Qiu, et al.
Published: (2024-09-01)

Effects of dietary dihydroartemisinin on growth performance, meat quality, and antioxidant capacity in broiler chickens
by: Xiaoxiao Pu, et al.
Published: (2025-01-01)

Glucose-functionalized redox-responsive dihydroartemisinin prodrug nanosystem for targeted malaria therapy
by: Rongrong Wang, et al.
Published: (2025-12-01)

Dihydroartemisinin induces tumor suppression in the Drosophila brain tumor with functional recovery and a rescue in lethality
by: Sushree Sulava, et al.
Published: (2025-08-01)

Dihydroartemisinin-sodium taurocholate-PLGA nanoparticles: a novel therapeutic approach against cystic echinococcosis
by: Aierpati Moheteer, et al.
Published: (2025-06-01)

Dihydroartemisinin Alleviates the Symptoms of a Mouse Model of Systemic Lupus Erythematosus Through Regulating Splenic T/B-Cell Heterogeneity
by: Haihong Qin, et al.
Published: (2025-07-01)

A non-randomized, open-label study to assess the impact of rounds of mass drug administration with artemisinin-piperaquine plus primaquine on malaria in São Tomé Island
by: Mingqiang Li, et al.
Published: (2025-05-01)

Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01)

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)

Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey
by: Elihuruma Eliufoo Stephano, et al.
Published: (2025-07-01)

Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
by: Huangde Fu, et al.
Published: (2025-02-01)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.
Published: (2025-02-01)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
by: Rachida Moussa Tari, et al.
Published: (2022-01-01)

Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis
by: Zhuoying Yang, et al.
Published: (2024-10-01)

RETRACTED: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
by: You-Cai Yi, et al.
Published: (2021-11-01)

Acceptability of self-collected vaginal swabs and point-of-care testing for sexually transmitted and genital infections among pregnant women in Papua New Guinea
by: Lisa M. Vallely, et al.
Published: (2024-12-01)

Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice
by: Jingjing Fang, et al.
Published: (2025-08-01)

ZIF-8 with encapsulated dihydroartemisinin in a drug delivery system for protection against Plasmodium berghei ANKA-induced experimental cerebral malaria in C57BL/6N mice
by: Yuting Li, et al.
Published: (2025-07-01)

Sexual health and wellbeing training with women in Pacific Island Countries and Territories: a scoping review
by: Nalisa Neuendorf, et al.
Published: (2021-01-01)

Intermittent screening using ultra-sensitive malaria rapid diagnostic test and treatment with pyronaridine-artesunate compared to standard preventive treatment with sulfadoxine-pyrimethamine for malaria prevention in pregnant women in Kinshasa, DRC
by: Japhet Kabalu Tshiongo, et al.
Published: (2025-02-01)

Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
by: Andria Mousa, et al.
Published: (2025-05-01)

Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trialsResearch in context
by: Enju Liu, et al.
Published: (2025-06-01)

Adherence to Dihydroartemisinin + Piperaquine Treatment Regimen in Low and High Endemic Areas in Indonesia
by: Irfanul Chakim, et al.
Published: (2022-01-01)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
by: Floriano Amimo, et al.
Published: (2020-11-01)

Engineered macrophage membrane-coated dihydroartemisinin nanoparticles with enhanced CCR2 expression improved symptoms in MRL/LPR mice by metabolic reprogramming of proinflammatory macrophages
by: Li Zhao, et al.
Published: (2025-06-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)